The Interaction of Microbiome and Pancreas in Acute Pancreatitis

Area of Science:

• Gastroenterology
• Microbiology
• Immunology

Background:

• Acute pancreatitis (AP) is a severe condition often complicated by infection and sepsis, increasing mortality.
• Gut microbiota dysbiosis is increasingly implicated in AP pathogenesis, affecting the gut-pancreas axis.
• Mechanisms include intestinal barrier dysfunction, inflammation, bacterial translocation, and altered microbial metabolites.

Purpose of the Study:

• To review the alterations in gut microbiota composition during acute pancreatitis.
• To elucidate the role of gut microbiota in modulating the gut-pancreas axis in AP.
• To explore novel therapeutic interventions targeting the gut microbiome for AP management.

Main Methods:

• Literature review of studies investigating gut microbiota in AP.
• Analysis of anatomical and epidemiological evidence linking dysbiosis to AP.
• Examination of research on microbial metabolites and their role in AP.

Main Results:

• Gut microbiota dysbiosis is a significant factor in AP etiology and severity.
• Alterations in gut bacteria influence intestinal permeability and systemic inflammation in AP.
• Microbial metabolites play a regulatory role in AP progression.

Conclusions:

• Gut microbiota dysbiosis is central to the gut-pancreas axis in acute pancreatitis.
• Targeting microbial communities presents promising therapeutic avenues for AP.
• Further research is needed to overcome challenges in applying microbiome-based interventions for AP diagnosis and treatment.